News
-
-
-
COMMUNIQUÉ DE PRESSE
Modalités de mise à disposition de prospectus
GenSight Biologics annonce la mise à disposition d'un prospectus pour l'admission d'actions nouvelles sur Euronext Paris. La société spécialisée dans les thérapies géniques pour les maladies neurodégénératives informe sur le processus -
-
-
-
COMMUNIQUÉ DE PRESSE
AS PlusPlus Capital Progresses in Restructuring Process – Application for Approval of Restructuring Plan Submitted to Court Following Investor Voting
PlusPlus Capital progresses in restructuring process, submits restructuring plan for court approval after investor voting. Approval expected with extensive support from creditors -
-
COMMUNIQUÉ DE PRESSE
Tecogen Acquires Additional Service Contracts
Tecogen Inc. acquires service agreements for 31 additional cogeneration units, totaling 83 this year, to enhance customer savings and profitability through increased uptime. CEO Abinand Rangesh emphasizes service revenue's importance. Tecogen specializes in high-efficiency, environmentally friendly cogeneration products for various applications -
